A team led by scientists at UGA's Odum School of Ecology has developed an algorithm that can accurately predict how a seasonal flu virus is expected to evolve. Such information may allow seasonal flu vaccines to be updated ...
Sep 9, 2024
0
11
A current strain of highly pathogenic avian influenza, commonly known as bird flu, has become a global problem. The virus has affected many millions of birds, some other animal species, and a small number of people.
Sep 3, 2024
0
0
This year's newly formulated COVID vaccines are expected to start shipping in the next few days after the FDA on August 22 officially approved and authorized the new shots.
Aug 24, 2024
0
2
High-dose and adjuvanted influenza (flu) vaccines boosted protection against flu symptoms and hospitalization for people 65 years and older during the 2022–2023 flu season compared to the standard flu vaccine.
Aug 22, 2024
0
1
Germany's BioNTech and US pharma giant Pfizer said Friday they had suffered a setback in a late-stage trial of their combined mRNA vaccine against COVID-19 and influenza.
Aug 16, 2024
0
7
A unique influenza vaccine candidate that's inhaled and based on technology developed by University of Wisconsin–Madison researchers is safe and could bolster protection against seasonal and pandemic influenza for people ...
Aug 15, 2024
0
31
A saliva test can more accurately indicate the severity of recurrent respiratory infections in children than the standard blood test. If saliva contains too few broadly protective antibodies, a child is more likely to suffer ...
Aug 8, 2024
0
14
The lightning-fast development of COVID-19 vaccines just months after the virus appeared was a triumph of modern science and saved millions of lives. But for all the good they did in reducing illnesses and deaths, the shots ...
Jul 31, 2024
0
67
New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called "one and done" vaccine that confers lifetime immunity against an evolving virus.
Jul 19, 2024
0
77
U.S. health officials announced Tuesday that the federal government will pay Moderna $176 million to speed development of a pandemic flu vaccine based on mRNA technology.
Jul 2, 2024
0
0
